Report of Independent Registered Public Accounting Firm
2
Balance Sheets
3
Statements of Operations and Other Comprehensive Income (Loss)
4
Statements of Stockholders’ Equity
5
Statements of Cash Flows
6
Notes to the Financial Statements
7- 13
1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and Board of Directors of Chemrex Corporation Sdn. Bhd.
No. 4, Jalan CJ 1/6
Kawasan Perusahaan Cheras Jaya
43200 Cheras
Selangor Darul Ehsan
Opinion on the Financial Statements
We have audited the accompanying balance sheets of Chemrex Corporation Sdn. Bhd. (the ‘Company’) as of December 31, 2019 and 2018, and the related statements of operations and other comprehensive income/(loss), stockholders’ equity, and cash flows for each of two years in years ended of December 31, 2019 and 2018, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as at December 31, 2019 and 2018, and the results of its operations and its cash flows for each of two years in the year ended December 31, 2019 and 2018, in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statements presentation. We believe that our audit provides a reasonable basis for our opinion.
We have served as the Company’s auditor since 2020.
/s/ JP Centurion & Partners PLT
JP Centurion & Partners PLT
Kuala Lumpur, Malaysia
March 31, 2021
2
Chemrex Corporation Sdn. Bhd.
Balance Sheets
December 31, 2019 and 2018
Expressed in United States Dollars
December 31,
December 31,
2019
2018
ASSETS
Current Assets
Inventories
$
1,315,627
$
1,293,943
Trade receivables
4,346,817
4,050,135
Other receivables, deposits and prepayments
73,295
20,841
Tax assets
-
8,348
Cash and bank balances
346,008
21,215
Total Current Assets
6,081,747
5,394,482
Property, plant and equipment, net
1,878,073
1,917,151
Other investments
147,882
67,157
Total Non-Current Assets
2,025,955
1,984,308
TOTAL ASSETS
$
8,107,702
$
7,378,790
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Trade payables
$
3,163,122
$
1,725,190
Accrued liabilities and other payables
608,216
112,142
Amount owing to Directors
-
914,482
Borrowings
3,258
659,008
Tax payable
31,182
-
Total Current Liabilities
3,805,778
3,410,822
Deferred tax liabilities
3,107
3,698
Borrowings
3,912
255,231
Total Non-Current Liabilities
7,019
258,929
TOTAL LIABILITIES
3,812,797
3,669,751
Stockholders' Equity
Share capital
395,306
395,306
Accumulated other comprehensive loss
(36,913
)
(82,420
)
Accumulated surplus
3,936,512
3,396,153
Total Stockholders’ Equity
4,294,905
3,709,039
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
$
8,107,702
$
7,378,790
The notes are an integral part of these financial statements.
3
Chemrex Corporation Sdn. Bhd.
Statements of Operations and Other Comprehensive Income (Loss)
For the Years Ended December 31, 2019 and 2018
Expressed in United States Dollars
For the Year Ended
December 31,
2019
2018
Revenue
$
15,417,992
$
11,904,853
Cost of revenue
(13,487,421
)
(10,381,987
)
Gross profit
1,930,571
1,522,866
Other income
89,504
115,387
Operating expenses - general and administrative
(1,277,055
)
(994,449
)
Profit from operations
743,020
643,804
Finance costs
(26,571
)
(62,254
)
Profit before provision for income taxes
716,449
581,550
Provision for income taxes
(176,090
)
(145,189
)
Net income
$
540,359
$
436,361
Other comprehensive income/(loss)
45,507
(82,420
)
Total comprehensive income
$
585,866
$
353,941
Basic and diluted income per share of common stock
$
0.34
$
0.27
Weighted average number of shares of common stock outstanding
1,600,000
1,600,000
The notes are an integral part of these financial statements.
4
Chemrex Corporation Sdn. Bhd.
Statements of Stockholders’ Equity
For the Years Ended December 31, 2019 and 2018
Expressed in United States Dollars
Share Capital
Accumulated
Other
Total
Number
of Shares
Amount
Accumulated
Surplus
Comprehensive
Income/(Loss)
Stockholders'
Equity
Balance - December 31, 2017
1,600,000
$
395,306
$
2,959,792
$
-
$
3,355,098
Net income
-
-
436,361
-
436,361
Other comprehensive loss
-
-
-
(82,420
)
(82,420
)
Balance - December 31, 2018
1,600,000
$
395,306
$
3,396,153
$
(82,420
)
$
3,709,039
Net income
-
-
540,359
-
540,359
Other comprehensive income
-
-
-
45,507
45,507
Balance - December 31, 2019
1,600,000
$
395,306
$
3,936,512
$
(36,913
)
$
4,294,905
The notes are an integral part of these financial statements
5
Chemrex Corporation Sdn. Bhd.
Statements of Cash Flows
For the Years Ended December 31, 2019 and 2018
Expressed in United States Dollars
For the Year Ended
December 31,
2019
2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income
$
540,359
$
436,361
Adjustment to reconcile profit to net cash from/(used in) operating activities:
Bad debts written off
7,224
3,593
Depreciation of property, plant and equipment
59,452
86,574
Dividend income
(2,574
)
(294
)
Fair value (gain)/loss of other investments
(17,459
)
15,832
Gain on disposal of property, plant and equipment
-
(3,469
)
Finance costs
26,571
62,254
Unrealized foreign exchange loss/(gain)
4,708
(35,876
)
Operating profit before changes in working capital
618,281
564,975
Changes in operating assets and liabilities:
Inventories
(8,090
)
37,196
Trade receivables
(266,120
)
(405,702
)
Other receivables, deposits and prepayments
(52,235
)
3,767
Trade payables
1,419,863
(224,491
)
Accrued liabilities and other payables
494,896
24,000
Amount owing to Directors
(924,089
)
145,068
Tax payable
38,988
(38,342
)
Net Cash Provided by Operating Activities
1,321,494
106,471
CASH FLOWS FROM INVESTING ACTIVITIES:
Addition in other investments
(62,348
)
(68,628
)
Dividend received
2,574
294
Proceeds from disposal of property, plant and equipment
-
3,385
Purchase of property, plant and equipment
(953
)
(40,245
)
Net Cash Used in Investing Activities
(60,727
)
(105,194
)
CASH FLOWS FROM FINANCING ACTIVITIES:
Interests paid
(26,571
)
(62,254
)
Repayment of term loans
(264,174
)
(12,368
)
(Repayment)/ Withdrawal of short-term borrowings
(510,829
)
125,740
Repayment of obligation under finance lease
(6,242
)
(10,781
)
Net Cash (Used in) / Provided by Financing Activities
(807,816
)
40,337
Effect of Exchange Rate Changes
5,862
944
Net increase in cash and cash equivalents
458,813
42,558
Cash and cash equivalents, beginning of the year
(112,805
)
(155,363
)
Cash and cash equivalents, end of the year
$
346,008
$
(112,805
)
The notes are an integral part of these financial statements.
6
Chemrex Corporation Sdn. Bhd.
Notes to the Financial Statements
December 31, 2019 and 2018
Expressed in United States Dollars
NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS
Chemrex Corporation Sdn. Bhd. (“we,” “us,” “our,” the “Company,” or “CCSB”) is a private limited liability company, incorporated in Malaysia.
The registered office of business of the Company is located at 87-2, Jalan Pudu Ulu, 56100, Kuala Lumpur.
Chemrex wholesales chemicals and resins for the manufacturers in industrial, medical components and equipment industries with customers located across South East Asia, Middle East and South India.
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The Financial Statements have been prepared using the accrual basis of accounting in accordance with Generally Accepted Accounting Principles (“GAAP”) of the United States and presented in United States dollars.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.
Foreign Currency Translation and Re-measurement
The Company translates its foreign operations to U.S. dollar in accordance with ASC 830, “Foreign Currency Matters”.
Translation of amounts from the local currency of the Company into US$1.00 has been made at the following exchange rates for the respective years:
December 31,
2019
December 31,
2018
Year-end USD : MYR exchange rate
4.093
4.136
January 1, 2019 to
December 31, 2019
January 1, 2018 to
December 31, 2018
Yearly average USD : MYR exchange rate
4.135
4.035
The Company’s functional currency is Malaysian Ringgit (“MYR”) and reporting currency is the U.S. dollar.
7
The Company translates its records into U.S. dollar as follows:
·
Assets and liabilities at the rate of exchange in effect at the balance sheet date
·
Equities at historical rate
·
Revenue and expense items at the average rate of exchange prevailing during the period
Financial Instruments
The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued liabilities and other payable, deferred revenue and due to related parties. The carrying amounts of such financial instruments approximate their respective estimated fair value due to the short-term maturities and approximate market interest rates of these instruments.
Property, plant and equipment
Property, plant and equipment are recorded at cost. Depreciation is calculated using straight line method over the estimated useful lives of the assets. The useful lives are as follows:
Buildings
50 years
Equipment
5 years
Furniture and fittings
10 years
Motor vehicle
5 years
Office equipment
5 years
Renovation
10 years
Signboard
10 years
Leased assets are depreciated over the shorter of the lease term and their useful lives unless it is reasonably certain that the Company will obtain ownership by the end of the lease term. Freehold land is not depreciated. Property, plant and equipment under construction are not depreciated until the assets are ready for their intended use.
Maintenance and repairs are charged to operations as incurred. Expenditures which substantially increase the useful lives of the related assets are capitalized. When properties are disposed of, the related costs and accumulated depreciation are removed from the accounts and any gain or loss is reported in the period the transaction takes place.
Accounting for the impairment of long-lived assets
The long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. It is reasonably possible that these assets could become impaired as a result of technology or other industry changes. Determination of recoverability of assets to be held and used is by comparing the carrying amount of an asset to future net undiscounted cash flows to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. During the year ended December 31, 2019 and 2018, the Company did not impair any long-lived assets.
Inventories
Inventories consisting of products available for sell, are stated at the lower of cost or market value. Cost of inventory is determined using the weighted average method. Inventory reserve is recorded to write down the cost of inventory to the estimated market value due to slow-moving merchandise and damaged goods, which is dependent upon factors such as historical and forecasted consumer demand, and promotional environment. The Company takes ownership, risks and rewards of the products purchased. Write downs are recorded in cost of revenues in the Condensed Statements of Operations and Comprehensive Income.
8
Leases
In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-02, Leases, which was subsequently amended in 2018 by ASU 2018-10, ASU 2018-11 and ASU 2018-20 (collectively, Topic 842). Topic 842 will require the recognition of a right-of-use asset and a corresponding lease liability, initially measured at the present value of the lease payments, for all leases with terms longer than 12 months. For operating leases, the asset and liability will be expensed over the lease term on a straight-line basis, with all cash flows included in the operating section of the statement of cash flows. For finance leases, interest on the lease liability will be recognized separately from the amortization of the right-of-use asset in the statement of comprehensive income and the repayment of the principal portion of the lease liability will be classified as a financing activity while the interest component will be included in the operating section of the statement of cash flows. Topic 842 is effective for annual and interim reporting periods beginning after December 15, 2018. Early adoption is permitted. Upon adoption, leases will be recognized and measured at the beginning of the earliest period presented using a modified retrospective approach. Topic 842 allows for a cumulative-effect adjustment in the period the new lease standard is adopted and will not require restatement of prior periods.
Prior to January 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective July 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The Company adopted ASC 842 using a modified retrospective approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods.
Revenue Recognition
Revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services.
The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:
·
identify the contract with a customer;
·
identify the performance obligations in the contract;
·
determine the transaction price;
·
allocate the transaction price to performance obligations in the contract; and
·
recognize revenue as the performance obligation is satisfied.
The Company records revenue at point in time which is recognized upon goods delivered or services rendered.
Income Taxes and Deferred Taxes
Tax expense in profit or loss comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to a business combination or items recognized directly in equity or other comprehensive income.
Deferred tax is recognized using the liability method for all temporary differences between the carrying amounts of assets and liabilities in the statement of financial position and their tax bases. Deferred tax is not recognized for the temporary differences arising from the initial recognition of goodwill, the initial recognition of assets and liabilities in a transaction which is not a business combination and that affects neither accounting nor taxable profit or loss. Deferred tax is measured at the tax rates that are expected to be applied to the temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the end of the reporting period.
Recent Accounting Pronouncements
Management has considered all recent accounting pronouncements issued. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.
9
NOTE 3 – TRADE RECEIVABLES
The Company has performed an analysis on all its trade receivables and determined that all amounts are collectible by the Company. As such, trade receivables are reflected as a current asset and no allowance for expected credit loss has been recorded as of December 31, 2019 and 2018. A total of $7,224 and $3,593 of bad debts were written off for the year ended December 31, 2019 and 2018, respectively. The Company’s trade receivables consist of receivable from customers which are unrelated to the Company. The account receivables are non-interest bearing and is generally on 30 days to 90 days term. As at December 31, 2019 and 2018, the Company recorded $4,346,817 and $4,050,135 trade receivables, respectively.
NOTE 4 – OTHER RECEIVABLES, DEPOSITS AND PREPAYMENTS
Other receivables, deposits and prepayments at December 31, 2019 and 2018 consist of the following:
December 31,
December 31,
2019
2018
Other receivables, deposits and prepayments
$
73,295
$
20,841
NOTE 5 – PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment at December 31, 2019 and 2018 consist of the following:
December 31,
December 31,
2019
2018
Cost:
Equipment
$
43,357
$
43,357
Furniture and fittings
83,373
82,528
Land and buildings
1,926,794
1,926,794
Motor vehicle
24,593
24,593
Office equipment
30,208
30,111
Renovation
105,448
105,448
Signboard
712
712
2,214,485
2,213,543
Less: accumulated depreciation
(290,287
)
(230,835
)
Foreign exchange translation
(46,125
)
(65,557
)
Property, plant and equipment, net
$
1,878,073
$
1,917,151
During the year ended December 31, 2019 and 2018, the Company recorded depreciation of $59,452 and $86,574, respectively.
10
NOTE 6 – OTHER INVESTMENTS
December 31,
December 31,
2019
2018
As of beginning of the year
$
67,157
$
14,280
Addition during the year
62,348
68,628
Fair value gain/(loss)
17,459
(15,832
)
Foreign exchange translation
918
81
As of end of the year
$
147,882
$
67,157
The other investments consist of investment in quoted shares in Malaysia.
NOTE 7 – CASH AND CASH EQUIVALENTS
For the purpose of presentation in the statement of cash flows, cash and cash equivalents consist of cash on hand, bank balances and deposits with licensed banks, with original maturities of three months or less that are readily convertible to known amounts of cash and subject to an insignificant risk of changes in value, net of bank overdrafts.
December 31,
December 31,
2019
2018
Cash and bank balances
$
346,008
$
21,215
Less: Bank overdraft
-
(134,020
)
Presented in statement of cash flows
$
346,008
$
(112,805
)
NOTE 8 – TRADE PAYABLES
Trade payables at December 31, 2019 and 2018 were $3,163,122 and $1,725,190, respectively. Trade payables are amounts billed to the Company by suppliers for goods and services in the ordinary course of business. All amounts have short-term repayment terms and vary by supplier.
NOTE 9 - ACCRUED LIABILITIES AND OTHER PAYABLES
Accrued liabilities and other payables at December 31, 2019 and 2018 consist of the following:
December 31,
December 31,
2019
2018
Accrued liabilities and other payables
$
608,216
$
112,142
Included in the accrued liabilities and other payables is an amount of $518,148 representing the deposits received for a disposal of property which completed in financial year December 31, 2020.
NOTE 10 – AMOUNT OWING TO DIRECTORS
The amount owing to Directors as at December 31, 2018 was unsecured, interest-free and repayable on demand. The amount was repaid in 2019.
11
NOTE 11 – BORROWINGS
The Company’s borrowings as at December 31, 2019 and 2018 are as follows:
December 31,
December 31,
2019
2018
Non-current
Finance lease liabilities
$
3,912
$
7,096
Term loan - secured
-
248,135
3,912
255,231
Current
Term loan - secured
-
13,293
Overdrafts
-
134,020
Short-term borrowings
-
505,518
Finance lease liabilities
3,258
6,177
3,258
659,008
$
7,170
$
914,239
The Company purchased motor vehicles under a finance lease agreement with principal and interest payable monthly.
The Company’s term loan is secured by pledging over the Company’s property and guaranteed by Directors and this loan was fully settled in 2019.
NOTE 12 - STOCKHOLDERS’ EQUITY
Ordinary shares
The Company has authorized share capital of MYR1,600,000. The holders of ordinary shares are entitled to receive dividends as declared from time to time and are entitled to one vote per share at meetings of the Company.
The Company has no stock option plan, warrants or other dilutive securities.
12
NOTE 13 – INCOME TAXES
The Company provides for income taxes under ASC 740, “Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax basis of assets and liabilities and the tax rates in effect when these differences are expected to reverse. It also requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.
The Company is operating in Malaysia and is subject to the Malaysia Corporate Tax which is charged at the statutory income tax rate range is 24% on its assessable income. Under the amendment of Income Tax Act 1967 by the Finance Act 2019 and with effect from year of assessment 2019 (2018: year of assessment 2018), companies with paid-up capital of MYR2.5 million or less, and with annual business income of not more than RM50 million are subject to Small and Medium Enterprise Corporate Tax at 17% (2018: 18%) on chargeable income up to MYR500,000 (2018: MYR500,000) except for companies with investment holding nature or companies does not have gross income from business sources are subject to corporate tax at 24% on chargeable income.
During the year ended December 31, 2019 and 2018, the Company recorded income taxes of $176,090 and $145,189, respectively.
NOTE 14 – SIGNIFICANT EVENTS
On 11 March 2020, the World Health Organization declared the Coronavirus (“Covid-19”) outbreak to be a pandemic, which has caused severe global social and economic disruptions and uncertainties, including markets where the Company operates or intends to operate. The Company is actively monitoring and managing its operations to respond to these changes, the Company does not consider it practicable to provide any quantitative estimate on the potential impact it may have on the Company as the outbreak continue to evolve as of the date of this report.
NOTE 15 - SUBSEQUENT EVENTS
Management has evaluated subsequent events through the date these financial statements were available to be issued. Based on our evaluation no material events have occurred that require disclosure.
13
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.
